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Background. The mechanisms of depressed left ventricular (LV) pump performance in human mitral stenosis (MS) remain poorly understood, because reduced filling alone affects many hemodynamic measurements. Therefore, pressure-volume relations were examined in nine subjects with MS and compared with eight age-matched normal controls.
Methods and Results. Data were obtained by conductance catheter/micromanometer technique with transient inferior vena cava occlusion used to alter load and generate pressure-volume relations. In a subset of patients (n=5), data were obtained both acutely and at 3 months (n=4) after balloon valvuloplasty. MS patients had reduced cardiac output (3.3±0.9 versus 5.6+1.7 I/min) and end-diastolic volume (68.0±6.9 versus 115±31 ml) versus controls (p<0.001), with a mean transvalvular gradient of 14±6 mm Hg and estimated valve area of 0.6+0.2 cm2. Systolic function as assessed by the end-systolic pressure-volume relation was virtually the same in MS and control subjects. In contrast, end-diastolic pressure-volume relations in MS were consistently shifted leftward and had an increased slope (lower compliance) at matched pressure ranges (6.5±3.0 versus 2.2±0.53 ml/mm Hg at a mean diastolic pressure of 8 mm Hg, p<0.001). This change was not a result of reduced LV filling or probably of increased right heart loading. Valvuloplasty acutely returned chamber compliance to near normal, a change that was sustained at 3-month follow-up. Systolic function was little altered at this time.
Conclusions. These data indicate an impairment of diastolic function in human MS that can be acutely reversed by balloon valvuloplasty. Lowered LV compliance probably results from a functional restriction caused by ventricular attachment to a thickened and immobile valve apparatus. (Circulation 1992; 85: 1447 -1456 KEY WoRDs * valves * ventricular function pressure-volume relation S ince 1955, when Harvey et all reported that some patients failed to increase their cardiac output after seemingly successful mitral commissurotomy, investigators have hypothesized the existence of primary ventricular dysfunction with rheumatic mitral stenosis (MS). Both systolic and diastolic abnormalities have been suggested to result from chronically reduced chamber loading ("disuse hypofunction"),2 endocardial fibrosis from rheumatic inflammation and/or vasculitis,3 elevated right heart loading and thus abnormal rightleft heart interactions,4 and valvular "tethering".5 Several investigations have attempted to characterize this dysfunction; however, the results have been contradic-nisms for abnormal chamber function with MS. Our results do not support the presence of primary systolic chamber dysfunction. However, they demonstrate significant abnormalities in diastolic compliance that can be rapidly reversed by valvuloplasty.
Methods
The study populations consisted of nine patients (age, 48±13 years) with pure rheumatic MS (MS group) and eight age-matched (40±12 years) control subjects. All (Millar, Houston, Tex.) placed across the pulmonary artery so that both right ventricular and pulmonary arterial pressures were obtained simultaneously.
All micromanometers were soaked in a warm water bath for at least 30 minutes before study and were calibrated to mercury manometers. Data signals were displayed and digitized at 200 Hz using a customdesigned 286 processor-based data acquisition system.
Protocol
PV data, right heart pressures, and cardiac outputs were obtained at baseline. Then venous return was transiently reduced by inflation of the balloon at the right atrial-IVC junction. After approximately 10 seconds, the balloon was deflated and hemodynamic status restored to baseline. This procedure was repeated several times. Catheters were removed, and the volume catheter was replaced with a standard ventriculography pigtail catheter. Single-plane right anterior oblique (RAO) left ventriculography (11-12 ml/sec nonionic contrast) was performed and used for volume signal calibration (see below).
Mitral Valvuloplasty Protocol
All nine patients with MS underwent double balloon valvuloplasty,9 generally 2 days after the baseline study described above. Right and left heart catheterization was performed by femoral approach for baseline hemodynamic measurements. The left atrium was entered via routine transseptal technique, and patients were then given heparin (100 units/kg i.v.). A double-lumen sheath (Mansfield, Boston, Mass.) was advanced to the left atrium, allowing passage of two exchange guide wires. A balloon dilatation catheter was placed over each guide wire and positioned across the mitral valve. The balloons were inflated with a 50% mixture of saline and contrast for no more than 30 seconds with maximal inflation pressures of 3-4 atm. Immediately after valvuloplasty, hemodynamic pressures and flow measurements were repeated. After the left heart catheter was removed, it was replaced with a volume/micromanometer catheter, and an IVC balloon occlusion catheter was advanced to the right atrium. PV relations were obtained as previously described. These 
Data Analysis
Steady-state chamber pressures, volumes, and other indices were determined from 5 or 6 sequential cardiac cycles, synchronized by the R wave of the ECG, and then signal averaged. End-diastolic pressure was defined at the lower right corner of the pressure-volume loop. This was automatically determined by finding the point of maximal (V-Vr)/(P-Pr) ratio, where V, is (minimal volume -5 ml) and P, is (minimal pressure -30 mm Hg) and using the pressure at this point. Endsystolic pressure was determined at the point of maximal P/(V-V0) ratio, using V0 obtained from the endsystolic PV relation (ESPVR) (see below).
End-diastolic and end-systolic volumes were determined by averaging five volume points centered at mean LV pressure during isovolumetric contraction and relaxation phases, respectively. In the patient with 2+ mitral regurgitation after PBMV, maximal volume at end-diastolic pressure was used. Stroke volume was the average width of the PV loop, and stroke work was the digitally integrated area within the loop.
The derivative of pressure (dP/dt) was determined using a five-point weighted running slope. The time constant of isovolumic relaxation was determined from linear regression of the natural logarithm of pressure versus time, using pressures between the point of dP/ dtmin to when P(t) fell below end-diastolic pressure.
End-Systolic and End-Diastolic PV Relations
In addition to steady-state parameters, PV relations were derived from multiple cardiac cycles (average, 12±4 beats) determined at varying preload by transient IVC occlusion. The end-systolic PV point for each beat was determined at maximal PI(V-VJ) using an iterative method described previously7 and the set of points fit by linear regression with slope Ees (end-systolic elastance) and volume intercept VO.
End-diastolic points from the latter third of cardiac filling were selected from each beat during IVC occlusion and used to derive the end-diastolic PV relation (EDPVR) as previously described. ESPURs, end-systolic pressure-volume relations; EDPUR, end-diastolic pressure-volume relations.
ESPVR fits) are graphically displayed in Figure 2 (upper panel).
In contrast to the systolic data, MS EDPVRs fell to the left of controls and had a steeper slope (Figure 2, Figure 2 (lower panel). Thus, diastolic PV data in MS patients did not simply reflect reduced filling volumes caused by restricted inflow but also indicated primary reduction in chamber compliance.
Integration of Systolic and Diastolic Changes
The net effect of an essentially unchanged systolic PV boundary relation and a leftward-shifted and steeper diastolic boundary could be indexed by the relation between stroke work and end-diastolic volume. Although this relation has been previously reported for assessment of systolic chamber performance, it can also be altered by changes in diastolic compliance. Stroke work links PV data between the diastolic and systolic boundaries (similar to developed pressure for isovolumic contractions); thus, abnormalities in either relation can affect the stroke work-end-diastolic volume relation. Stroke work-end-diastolic volume relations were obtained using the same PV loops during transient IVC occlusion used to construct the ESPVRs and EDPVRs.
The slopes for these relations ( Figure 3) does not entirely rule out a role for right ventricle-LV interaction, but it minimizes the likelihood that it is a major mechanism.
To examine the latter three mechanisms, data obtained before and after PBMV were compared. All nine MS subjects underwent valvuloplasty, and PV relations were obtained acutely (30 minutes after the procedure) in five and at 3-month follow-up in four of these patients.
Hemodynamic and PV relation mean responses before and after valvuloplasty are provided in Tables 3  and 4 . Heart rate, ejection fraction, and peak pulmonary artery pressure did not significantly change acutely. Estimated valve area and cardiac output, however, increased to 1.7+0.6 cm2 and 5.5±+ 1.0 1/min, respectively (both p<0.05 versus before PBMV). Enddiastolic volume also rose by 29.2±25.7 ml (+45%, p<0.05), whereas end-diastolic pressures increased only slightly (3.9±4.6 mm Hg, p=0.07). Generally similar findings were obtained in the four subjects at 3-month follow-up after valvuloplasty. End-diastolic volume continued to increase by an additional 22.8% from baseline (p<0.05). Pulmonary artery pressures also fell (mean, -18.7 mm Hg).
In addition to enhanced chamber volumes, compliance also increased both acutely and 3 months after PBMV. Figure 4 shows EDPVR data from one patient before and acutely following PBMV. Regressions for both upper and lower halves of each relation are also shown. There was a marked reduction in the slope of the relation after PBMV (in both load ranges), indicating increased compliance. Group data are provided in Table 4 and Figure 4 . In the upper-half range of the EDPVRs, compliance increased from 2.3±0.6 to 5.6±1.3 ml/mm Hg (p<0.001) acutely after valvuloplasty, bringing it close to control values. This occurred with no change in the mean diastolic pressure measured over the same range (8 ±2.8 versus 8.1±8.6 mm Hg). At 3-month follow-up, diastolic compliance remained at 5.9±2.5 ml/mm Hg (p<0.05 versus before valvuloplasty). The slope of the ESPVR fell acutely after PBMV by 62.2±16.4% (p<0.01), perhaps reflecting transient ischemic effects induced by PBMV. However, Ees returned to normal at 3-month follow-up.
Comparison With Other Valvuloplasty Patient Data
To assess how representative these pre-and post-PBMV results were of the larger MS population, we reviewed data from all patients who underwent PBMV during the 11/2-year period of the study (n=58, all subjects Taiwanese). Mean age, body weight, height, and estimated surface area for these additional 49 patients were identical to those reported for the study group. Ventriculographic data were obtained in a random sample of these patients (n =21). In nine of the 21 subjects, baseline end-diastolic volume was less than 100 ml (78±12.6 ml), similar to the study group, whereas the remaining subjects had baseline end-diastolic volume >100 ml (128.3+ 16.3). Interestingly, PBMV resulted in an acute volume increase only in those subjects with small baseline volumes (+19±25% versus 0.3±8.6% in the other subgroup, p<0.05). Patients with larger volumes had three times the incidence of significant coexistent aortic insufficiency, whereas mitral regurgitation both at baseline and after PBMV was similar in both groups. Thus, small baseline chamber volumes and acute increases in end-diastolic volume after PBMV were not unique to the principal study group reported above but rather represented the response in as much as 50% of MS subjects undergoing PBMV. These results also suggest that in chambers with normal or increased volumes at baseline, PBMV was unlikely to lead to further acute dilation. Discussion The principal findings of the present study are that ESPVRs differ little between control and MS subjects; however, the EDPVRs are both steeper (reduced compliance) and shifted leftward. Furthermore, these diastolic abnormalities can be acutely reversed by mitral valvuloplasty. This procedure provides a unique method to assess and separate acute and chronic functional changes caused by mechanical valve alteration with little direct effect on the myocardium. On the basis of these data, we propose that increased diastolic chamber stiffness with MS does not result from a permanent myocardial abnormality but rather represents a functional restriction, perhaps a result of mechanical constraining effects of a thickened immobile valve apparatus.
Systolic Function in MS
Although it has long been recognized that a subset of patients with rheumatic MS fail to respond to mechanical efforts to improve valve orifice size, the mechanisms underlying this observation remain unclear. Early studies focused on concomitant atrial fibrillation13 or abnormal pulmonary pressures.1"4"14 However, a primary "myocardial factor" with fibrosis was subsequently proposed,3'15 perhaps the consequence of inflammatory carditis, which could reduce LV systolic function. Evidence for dysfunction was based on examinations of ejection fraction, stroke work indices, end-systolic pressure/volume or stress/volume ratios, ejection fraction-wall stress relations, and wall motion abnormalities.2 '16-20 Unfortunately, the results have conflicted with interpretations dependent upon the nature of the functional assessments themselves. For example, dP/dt/PmX, has reportedly been reduced by MS20; however, the load sensitivity of this measurement makes its interpretation unclear. In another study, Gash et al'7 found no significant contractile depression measured by the ratio of end-systolic wall stress/end-systolic volume index. In contrast, Kaku et a12 reported a lower ejection fraction at any given level of wall stress in MS subjects versus controls, which was interpreted as evidence for myocardial depression. Mean arterial resistance, however, was 61% higher in the MS patients, and ejection fraction is known to vary with vascular resistance.2' Using equations to predict ejection fraction from PV relations,22 one can show that a 61% increase in systemic resistance alone (no change in systolic function, i.e., ESPVR) reduces ejection fraction from 65% to 53%. This is very close to the 65%-versus-48% values reported in the Kaku study.
In all these earlier studies, ventricular function was assessed at a single steady-state condition, and relations between load and function index were obtained by pooling multiple patients. This is distinctly different from the analysis of the present study, in which loading was varied within each patient to obtain the systolic function measurement. Only one other previous study attempted such an The current data address many of these hypotheses. Our estimation of compliance was based not on a single steady-state beat analysis but on combined late diastolic PV data from multiple beats at varying preload volumes. We have previously shown this to be valuable for separating out effects of chamber load (from right ventricle or perhaps pericardium interactions) and early relaxation and filling from intrinsic chamber diastolic properties.8 Two observations suggest that right ventricular loading was not a major factor: 1) the EDPVRs were obtained while the right ventricle was substantially unloaded (via IVC occlusion), and 2) the immediate post-PBMV data demonstrated a marked increase in chamber compliance despite almost identical right heart pressures. Although endocardial fibrosis could be present, valvuloplasty should not acutely alter the structure of the myocardium; thus, this mechanism is inconsistent with the immediate post-valvuloplasty data. Another hypothesis, that of chronic cardiac remodeling and/or atrophy resulting from low filling," would also appear less prominent because the EDPVRs were restored so quickly after valvuloplasty. Chamber volumes continued to increase another 25% during the 3-month follow-up period, however, so chamber remodeling could still play a secondary role in the diastolic abnormalities with MS.
The most compelling mechanism is mechanical, related to the immobility of the valve apparatus tethered via the chordae and papillary muscles to the ventricular chamber. In a sense, the valve apparatus acts much like pericardial constriction -but inside the heart. In addition to restricted filling as a result of the narrowed orifice area, the tethering of the muscle wall to the immobile valve ring increases the apparent diastolic stiffness much as a constraining membrane on the The acute PBMV data, both in the study group and in the nine additional subjects who also had reduced baseline volumes, however, suggest that this "smallness" can be rapidly reversed. Acute increases in filling volumes in a dog heart, for example, do not result in PV data typical of a human heart. It is for this reason that we favor the alternative interpretation: that dysfunction with MS is a result of a mechanical constraint and that release of this constraint reveals relatively normal underlying myocardial chamber properties. Most likely, the truth is somewhere in between, with cardiac remodeling (smallness) and a mechanical constraint both playing roles.
Stroke Work: End-Diastolic Volume Relations
An interesting finding in the present study was reduction of the slope of the stroke work-end-diastolic volume relation, which occurred despite the similar ESPVR slopes. The former has been proposed as a measure of chamber systolic function,27 and in many previous animal studies, it correlates directly with changes in chamber end-systolic elastance.28 A major caveat, which is often ignored, is that the diastolic properties must be comparable and normal for this index to reflect systolic properties. Like developed pressure, stroke work links diastolic and systolic PV boundaries, and changes in either one can limit net external work. The steepness and leftward shift of the EDPVRs in the MS patients indeed represent a profound difference in diastolic properties compared with normal (extend the group relation in Figure 2 so that it overlaps with the normal volume range to appreciate this). Indeed, at 3-month follow-up after valvuloplasty, with little change in E,, from control, the slope of the stroke work-end-diastolic volume relation had increased by 24% (p=0.046, by Friedman). Investigators using the stroke work-end-diastolic volume relation must bear in mind diastolic property changes when interpreting this index.
Limitations
The major limitation of this study is the lack of precise three-dimensional geometric data for each beat during preload change, so that stress-strain analysis could not be used. As a result, we can address chamber but not estimated myocardial function indices. Nevertheless, the data are important, because it is chamber function that determines observed hemodynamic variables such as cardiac output 
Conclusions
We have demonstrated in patients with severe pure rheumatic MS that systolic chamber function is nearly identical to age-matched controls, whereas the diastolic compliance is reduced and the PV relations shifted to lower volumes. Furthermore, the nearly immediate recovery of diastolic compliance after balloon mitral valvuloplasty suggests that the latter change is probably not because of intrinsic myocardial fibrosis nor primarily the result of chronic chamber remodeling and/or atrophy. Instead, the compliance reduction appears to be a consequence of a functional restriction from tethering to a rigid valve apparatus. These data support the notion that mobilization of a stenosed mitral valve, whether surgically or by valvuloplasty, can improve overall cardiac performance by mechanisms other than pure increase in orifice size.
